EverydayHealthLogo
Dr. Albert Koong, MD, PHD

Dr. Albert Koong, MD, PHD

Houston, TX

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Koong, Radiation Oncologist in Houston, TX?

    Dr. Albert Koong, MD, PHD is a Radiation Oncologist, who primarily practices in Houston, TX with 2 additional practice locations. He is board certified by the American Board of Radiology. Dr. Koong completed his residency at Stanford University School of Medicine. Dr. Koong is fluent in English and Chinese, and is currently seeing new patients. Dr. Koong’s practice accepts Medicare, Aetna, Cigna, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Koong’s office at (713) 792-6161.

    What are Areas of Expertise for Dr. Koong?

    Dr. Albert Koong, MD, PHD is a highly-rated, board-certified Radiation Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Koong empowers patients to confidently navigate their health journey, specializing in Gastrointestinal Cancer, Liver Cancer, Pancreatic Cancer, or comprehensive wellness support. Serving the Houston/TX community, Dr. Koong is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Koong go to medical school and complete their residency?

    • Residency: Stanford University School of Medicine

    Is Dr. Koong board certified in Radiation Oncologist?

    Yes, Dr. Albert Koong, MD, PHD is board certified by the American Board of Radiology since 2001

    What languages does Dr. Koong speak?

    Dr. Koong and their clinical team can communicate with patients in the following languages:

    • Chinese

    • English

    Which procedures does Dr. Koong perform as a Radiation Oncologist?

    As a Radiation Oncologist, procedures performed by a Dr. Albert Koong may include:

    For detailed information, please contact Dr. Koong's office.

    Does Dr. Koong accept my insurance?

    Dr. Koong accepts most major insurance plans. Important: Please call our office at (713) 792-6161 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Koong accept in Houston, TX?

    Dr. Koong in Houston, TX accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • Aetna

    • Blue Cross Blue Shield

    • Blue Cross Blue Shield of Illinois

    • Blue Cross Blue Shield of Michigan

    • Capital Blue Cross

    • Cigna

    • CMS

    • Elevance Health Inc. (formerly Anthem)

    • Harvard Pilgrim

    • Medicare

    View All Insurances

    Where is Dr. Koong's office located?

    Dr. Albert Koong's Primary Practice

    2130 W Holcombe Blvd # M

    Houston, TX 77030

    (713) 792-6161

    Get Directions

    Dr. Albert Koong's Practice 2

    1515 Holcombe Blvd Unit 1422

    Houston, TX 77030

    (713) 563-2300

    Get Directions

    Dr. Albert Koong's Practice 3

    6655 Travis St Ste 650

    Houston, TX 77030

    Get Directions

    Recognitions

    Publications

    X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas.

    Translatiol oncology, 2009

    XBP-1 regulates angiogenesis in human pancreatic adenocarcinomas

    TRANSLATIOL ONCOLOGY, 2009

    Multiplexed protein detection by proximity ligation for cancer biomarker validation

    TURE METHODS, 2007

    Connective tissue growth factor

    CANCER RESEARCH, 2006

    Galectin-1: A link between tumor hypoxia and tumor immune privilege

    JOURL OF CLINICAL ONCOLOGY, 2005

    Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

    Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer

    SEMIRS IN RADIATION ONCOLOGY, 2014

    Safety of (90)y radioembolization in patients who have undergone previous exterl beam radiation

    Intertiol jourl of radiation oncology, biology, physics, 2013

    A novel aldehyde dehydrogese-3 activator

    Clinical cancer research, 2013

    Seventh Edition (2010) of the AJCC

    ANLS OF SURGICAL ONCOLOGY, 2013

    Dosimetric alysis of organs at risk during expiratory gating

    Intertiol jourl of radiation oncology, biology, physics, 2013

    Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer

    Anls of surgical oncology

    Metabolic Tumor Volume Predicts Disease Progression

    JOURL OF NUCLEAR MEDICINE, 2013

    Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon

    AMERICAN JOURL OF SURGICAL PATHOLOGY, 2012

    Quantitation of Human Papillomavirus D in Plasma of Oropharyngeal Carcinoma Patients

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    A Novel Aldehyde Dehydrogese-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo

    CLINICAL CANCER RESEARCH, 2011

    Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Alysis

    CANCER, 2011

    Intensity-Modulated Radiation Therapy Versus Conventiol Radiation Therapy for Squamous Cell

    CANCER, 2011

    Unfolded Protein Response Regulation in Keloid Cells

    JOURL OF SURGICAL RESEARCH, 2011

    Stereotactic Body Radiation Therapy for Gastrointestil Maligncies

    IMRT IGRT SBRT- ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RAD, 2011

    A DOSIMETRIC MODEL OF DUODEL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER

    Murphy, J. D., Christman-Skieller, C., Kim, J., Dieterich, S., Chang, , 2010

    Comparison of Intensity-Modulated Radiotherapy

    Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No, 2010

    (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

    TRANSLATIOL ONCOLOGY, 2010

    EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer

    GASTROINTESTIL ENDOSCOPY, 2010

    INTERFRACTIOL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Identification of a biomarker panel using a multiplex proximity ligation

    JOURL OF TRANSLATIOL MEDICINE, 2009

    Pancreatic Tumor Motion on a Single Planning 4D

    AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009

    Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology

    AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009

    A Primer on Image-guided Radiation Therapy for the Interventiol Radiologist

    JOURL OF VASCULAR AND INTERVENTIOL RADIOLOGY, 2009

    Impaired interferon sigling is a common immune defect in human cancer

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2009

    THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS STATUS AND OTHER MOLECULAR PROGNOSTIC MARKERS IN HEAD

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy

    JOURL OF VASCULAR AND INTERVENTIOL RADIOLOGY, 2009

    Gemcitabine chemotherapy

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    In vivo H-1 magnetic resonce spectroscopy of lactate in patients with Stage IV head

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    High-dose single-fraction radiotherapy: Exploiting a new biology?

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer

    EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008

    Automated contour mapping with a regiol deformable model

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Tissue effects after stereotactic body radiotherapy using cyberknife

    CLINICAL ONCOLOGY, 2008

    Expression and prognostic significance of a panel of tissue hypoxia markers in head-and

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

    Quantitative PET of EGFR expression in xenograft-bearing mice using Cu-64-labeled cetuximab

    EUROPEAN JOURL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007

    Evaluation of patterns of failure

    HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2007

    Plasma osteopontin is an independent prognostic marker for head and neck cancers

    JOURL OF CLINICAL ONCOLOGY, 2006

    Results of a phase I dose-escalation study using single

    JOURL OF THORACIC ONCOLOGY, 2006

    Four-dimensiol cone-beam computed tomography using an on-board imager

    MEDICAL PHYSICS, 2006

    An evaluation of tumor oxygetion

    CLINICAL CANCER RESEARCH, 2006

    Identification of mitogen

    MOLECULAR CANCER RESEARCH, 2005

    Radiation dose reduction in four-dimensiol computed tomography

    MEDICAL PHYSICS, 2005

    Phase II study to assess the efficacy of conventiolly fractioted radiotherapy followed by a

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

    A noninvasive approach for assessing tumor hypoxia in xenografts

    CANCER RESEARCH, 2005

    Phase II double-blind r

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

    Improved local control with stereotactic radiosurgical boost

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003

    Comparison of the comet assay

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003

    Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003

    Estimating D repair by sequential evaluation of head

    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002

    HYPOXIC ACTIVATION OF NUCLEAR FACTOR-KAPPA

    CANCER RESEARCH, 1994

    MODULATION OF POTASSIUM CHANNELS BY PROTEIN-TYROSINE KISE INHIBITORS

    JOURL OF CELLULAR PHYSIOLOGY, 1994

    ACTIVATORS OF PROTEIN-KISE

    Koong, A. C., CHEN, E. Y., Kim, C. Y., Giaccia, A. J., 1994

    ALYSIS OF HSF-1 PHOSPHORYLATION IN A549 CELLS TREATED WITH A VARIETY OF STRESSES

    INTERTIOL JOURL OF HYPERTHERMIA, 1994

    THE REGULATION OF GRP78 AND MESSENGER-R LEVELS BY HYPOXIA IS MODULATED BY PROTEIN

    Koong, A. C., AUGER, E. A., CHEN, E. Y., Giaccia, A. J., 1994

    INCREASED CYTOTOXICITY OF CHRONIC HYPOXIC CELLS BY MOLECULAR INHIBITION OF GRP78 INDUCTION

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994

    ACTIVATION OF POTASSIUM CHANNELS BY HYPOXIA AND REOXYGETION IN THE HUMAN LUNG ADENOCARCINOMA CELL

    JOURL OF CELLULAR PHYSIOLOGY, 1993

    POTASSIUM-CHANNEL ACTIVATION IN RESPONSE TO LOW

    PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 1993

    ACTIVATION OF THE HEAT-SHOCK TRANSCRIPTION FACTOR BY HYPOXIA IN NORMAL AND TUMOR

    INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992

    THE INFLUENCE OF CHRONIC ANEMIA ON THE RADIOSENSITIVITY OF 2 MOUSE-TUMORS

    BRITISH JOURL OF CANCER

    Cost-effectiveness of modern radiotherapy techniques in locally advanced pancreatic cancer

    CANCER, 2012

    Identification of an Ire1alpha endonucle

    BLOOD, 2011

    Imaging the Unfolded Protein Response

    CANCER RESEARCH, 2010

    X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas.

    Translational oncology, 2009

    XBP-1 regulates angiogenesis in human pancreatic adenocarcinomas

    TRANSLATIONAL ONCOLOGY, 2009

    Stereotactic Radiotherapy for Unresectable Adenocarcinoma of the Pancreas

    CANCER, 2009

    The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF

    CANCER RESEARCH, 2009

    Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the

    CANCER CELL, 2009

    Multiplexed protein detection by proximity ligation for cancer biomarker validation

    NATURE METHODS, 2007

    Connective tissue growth factor

    CANCER RESEARCH, 2006

    Galectin-1: A link between tumor hypoxia and tumor immune privilege

    JOURNAL OF CLINICAL ONCOLOGY, 2005

    The unfolded protein response: A novel component of the hypoxic stress response in tumors

    MOLECULAR CANCER RESEARCH, 2005

    Identification of hypoxia

    CANCER RESEARCH, 2004

    XBP1 is essential for survival under hypoxic conditions and is required for tumor growth

    CANCER RESEARCH, 2004

    Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

    Pancreatic tumors show high levels of hypoxia

    Koong, A. C., Mehta, V. K., Le, Q. T., Fisher, G. A., Terris, D. J., B, 2000

    Loss of PTEN facilitates HIF-1-mediated gene expression

    GENES & DEVELOPMENT, 2000

    Candidate genes for the hypoxic tumor phenotype

    CANCER RESEARCH, 2000

    Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer

    SEMINARS IN RADIATION ONCOLOGY, 2014

    Safety of (90)y radioembolization in patients who have undergone previous external beam radiation

    International journal of radiation oncology, biology, physics, 2013

    A novel aldehyde dehydrogenase-3 activator

    Clinical cancer research, 2013

    Seventh Edition (2010) of the AJCC

    ANNALS OF SURGICAL ONCOLOGY, 2013

    Dosimetric analysis of organs at risk during expiratory gating

    International journal of radiation oncology, biology, physics, 2013

    Chemoradiotherapy Before and After Surgery for Locally Advanced Esophageal Cancer

    Annals of surgical oncology

    Metabolic Tumor Volume Predicts Disease Progression

    JOURNAL OF NUCLEAR MEDICINE, 2013

    Normal Tissue Complication Probability Modeling of Acute Hematologic Toxicity

    Bazan, J. G., Luxton, G., Mok, E. C., Koong, A. C., Chang, D. T., 2012

    Postchemoradiotherapy Positron Emission Tomography Predicts Pathologic Response

    Jayachandran, P., Pai, R. K., Quon, A., Graves, E., Krakow, T. E., La,, 2012

    Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Positron Emission Tomography for Predicting Pathologic Response After Neoadjuvant Chemoradiotherapy

    Chennupati, S. K., Quon, A., Kamaya, A., Pai, R. K., La, T., Krakow, T, 2012

    Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma

    MODERN PATHOLOGY, 2012

    A novel epidermal growth factor receptor variant lacking multiple domains directly activates

    ONCOGENE, 2012

    Orthovoltage Intraoperative Radiotherapy for Locally Advanced and Recurrent Colorectal Cancer

    DISEASES OF THE COLON & RECTUM, 2012

    Evaluation of the geometric accuracy of surrogate

    MEDICAL PHYSICS, 2012

    BRAF-mutated, Microsatellite-stable Adenocarcinoma of the Proximal Colon

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012

    Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma

    Abelson, J. A., Murphy, J. D., Minn, A. Y., Chung, M., Fisher, G. A., , 2012

    Quantitation of Human Papillomavirus DNA in Plasma of Oropharyngeal Carcinoma Patients

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

    Modern Radiation Therapy Techniques for Pancreatic Cancer

    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2012

    Antiangiogenic and Radiation Therapy Early Effects on In Vivo Computed Tomography Perfusion

    INVESTIGATIVE RADIOLOGY, 2012

    A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo

    CLINICAL CANCER RESEARCH, 2011

    Stereotactic Body Radiotherapy for Colorectal Liver Metastases A Pooled Analysis

    CANCER, 2011

    Intensity-Modulated Radiation Therapy Versus Conventional Radiation Therapy for Squamous Cell

    CANCER, 2011

    Tumor Galectin-1 Mediates Tumor Growth and Metastasis through Regulation of T-Cell Apoptosis

    CANCER RESEARCH, 2011

    Unfolded Protein Response Regulation in Keloid Cells

    JOURNAL OF SURGICAL RESEARCH, 2011

    Rectal and bladder deformation and displacement during preoperative radiotherapy for rectal cancer

    Practical radiation oncology, 2011

    Stereotactic Body Radiation Therapy for Gastrointestinal Malignancies

    IMRT IGRT SBRT- ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RAD, 2011

    A DOSIMETRIC MODEL OF DUODENAL TOXICITY AFTER STEREOTACTIC BODY RADIOTHERAPY FOR PANCREATIC CANCER

    Murphy, J. D., Christman-Skieller, C., Kim, J., Dieterich, S., Chang, , 2010

    Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate

    Chang, D. T., Chapman, C. H., Norton, J. A., Visser, B., Fisher, G. A., 2010

    Orthovoltage intraoperative radiation therapy for pancreatic adenocarcinoma

    RADIATION ONCOLOGY, 2010

    Comparison of Intensity-Modulated Radiotherapy

    Minn, A. Y., Hsu, A., La, T., Kunz, P., Fisher, G. A., Ford, J. M., No, 2010

    (18)FLUORODEOXYGLUCOSE PET IS PROGNOSTIC OF PROGRESSION

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Pathological response after chemoradiation for T3 rectal cancer

    COLORECTAL DISEASE, 2010

    Pathological response after chemoradiation for T3 rectal cancer.

    Colorectal disease, 2010

    Cetuximab-Based Immunotherapy and Radioimmunotherapy of Head and Neck Squamous Cell Carcinoma

    CLINICAL CANCER RESEARCH, 2010

    Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

    TRANSLATIONAL ONCOLOGY, 2010

    The RGD Domain of Human Osteopontin Promotes Tumor Growth

    PLOS ONE, 2010

    EUS-guided gold fiducial insertion for image-guided radiation therapy of pancreatic cancer

    GASTROINTESTINAL ENDOSCOPY, 2010

    INTERFRACTIONAL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

    Multimodality treatment with intensity modulated radiation therapy for esophageal cancer

    DISEASES OF THE ESOPHAGUS, 2010

    Identification of a biomarker panel using a multiplex proximity ligation

    JOURNAL OF TRANSLATIONAL MEDICINE, 2009

    Re: The safety and efficacy of robotic image-guided radiosurgery system treatment for intra

    RADIOTHERAPY AND ONCOLOGY, 2009

    Oxygen Consumption Can Regulate the Growth of Tumors, a New Perspective on the Warburg Effect

    PLOS ONE, 2009

    Pancreatic Tumor Motion on a Single Planning 4D

    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009

    Treatment of Esophageal Cancer Based on Histology A Surveillance Epidemiology

    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009

    A Primer on Image-guided Radiation Therapy for the Interventional Radiologist

    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009

    Impaired interferon signaling is a common immune defect in human cancer

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2009

    THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS STATUS AND OTHER MOLECULAR PROGNOSTIC MARKERS

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

    Detection of Solitary Humeral Metastasis From Pancreatic Adenocarcinoma With F-18 FDG PET/CT

    CLINICAL NUCLEAR MEDICINE, 2009

    Safety and Efficacy of Percutaneous Fiducial Marker Implantation for Image-guided Radiation Therapy

    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2009

    Gemcitabine chemotherapy

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    In vivo H-1 magnetic resonance spectroscopy of lactate in patients with Stage IV head

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    High-dose single-fraction radiotherapy: Exploiting a new biology?

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Molecular Imaging of Hypoxia-Inducible Factor 1 alpha and von Hippel-Lindau Interaction in Mice

    MOLECULAR IMAGING, 2008

    Reducing respiratory motion artifacts in radionuclide imaging through retrospective stacking

    LINEAR ALGEBRA AND ITS APPLICATIONS, 2008

    Initial evaluation of F-18-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer

    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008

    Multiplexed proximity ligation assays to profile putative plasma biomarkers

    CLINICAL CHEMISTRY, 2008

    Automated contour mapping with a regional deformable model

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

    Tissue effects after stereotactic body radiotherapy using cyberknife

    CLINICAL ONCOLOGY, 2008

    Preoperative versus postoperative radiotherapy for locally advanced gastroesophageal junction

    DISEASES OF THE ESOPHAGUS, 2008

    Enhanced 4D cone-beam CT with inter-phase motion model

    MEDICAL PHYSICS, 2007

    Expression and prognostic significance of a panel of tissue hypoxia markers in head-and

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

    Quantitative PET of EGFR expression in xenograft-bearing mice using Cu-64-labeled cetuximab

    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007

    Evaluation of patterns of failure

    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND, 2007

    Impact of integrated PET/CT on variability of target volume delineation in rectal cancer

    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2007

    Stereotactic body radiotherapy for unresectable pancreatic cancer

    IMRT, IGRT, SBRT: ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF R, 2007

    Plasma osteopontin is an independent prognostic marker for head and neck cancers

    JOURNAL OF CLINICAL ONCOLOGY, 2006

    Results of a phase I dose-escalation study using single

    JOURNAL OF THORACIC ONCOLOGY, 2006

    Four-dimensional cone-beam computed tomography using an on-board imager

    MEDICAL PHYSICS, 2006

    Reducing respiratory motion artifacts

    MEDICAL PHYSICS, 2006

    Targeting XBP-1 as a novel anti-cancer strategy

    CANCER BIOLOGY & THERAPY, 2006

    Overview of image-guided radiation therapy

    MEDICAL DOSIMETRY, 2006

    Mature results from a randomized phase II trial of cisplatin plus 5

    CANCER, 2006

    An evaluation of tumor oxygenation

    CLINICAL CANCER RESEARCH, 2006

    Identification of mitogen

    MOLECULAR CANCER RESEARCH, 2005

    Radiation dose reduction in four-dimensional computed tomography

    MEDICAL PHYSICS, 2005

    Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

    Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a ras-activated enhancer

    ONCOGENE, 2005

    A noninvasive approach for assessing tumor hypoxia in xenografts

    CANCER RESEARCH, 2005

    Sample classification from protein mass spectrometry, by 'peak probability contrasts'

    BIOINFORMATICS, 2004

    Phase II double-blind r

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

    The use of plasma surface-enhanced laser desorption

    CLINICAL CANCER RESEARCH, 2004

    Identification of hypoxia regulated proteins

    Cancer Res, 2004

    Improved local control with stereotactic radiosurgical boost

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003

    Comparison of the comet assay

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003

    Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003

    Identification of osteopontin as a prognostic plasma marker for head

    CLINICAL CANCER RESEARCH, 2003

    Estimating DNA repair by sequential evaluation of head

    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2002

    Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment

    CLINICAL CANCER RESEARCH, 2000

    HYPOXIC ACTIVATION OF NUCLEAR FACTOR-KAPPA

    CANCER RESEARCH, 1994

    MODULATION OF POTASSIUM CHANNELS BY PROTEIN-TYROSINE KINASE INHIBITORS

    JOURNAL OF CELLULAR PHYSIOLOGY, 1994

    ACTIVATORS OF PROTEIN-KINASE

    Koong, A. C., CHEN, E. Y., Kim, C. Y., Giaccia, A. J., 1994

    ANALYSIS OF HSF-1 PHOSPHORYLATION IN A549 CELLS TREATED WITH A VARIETY OF STRESSES

    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1994

    THE REGULATION OF GRP78 AND MESSENGER-RNA LEVELS BY HYPOXIA IS MODULATED BY PROTEIN

    Koong, A. C., AUGER, E. A., CHEN, E. Y., Giaccia, A. J., 1994

    HYPOXIA CAUSES THE ACTIVATION OF NUCLEAR FACTOR KAPPA-B THROUGH THE PHOSPHORYLATION OF I

    CANCER RESEARCH, 1994

    INCREASED CYTOTOXICITY OF CHRONIC HYPOXIC CELLS BY MOLECULAR INHIBITION OF GRP78 INDUCTION

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994

    ACTIVATION OF POTASSIUM CHANNELS BY HYPOXIA AND REOXYGENATION IN THE HUMAN LUNG ADENOCARCINOMA CELL

    JOURNAL OF CELLULAR PHYSIOLOGY, 1993

    POTASSIUM-CHANNEL ACTIVATION IN RESPONSE TO LOW

    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 1993

    ACTIVATION OF THE HEAT-SHOCK TRANSCRIPTION FACTOR BY HYPOXIA IN NORMAL AND TUMOR

    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1992

    THE INFLUENCE OF CHRONIC ANEMIA ON THE RADIOSENSITIVITY OF 2 MOUSE-TUMORS

    BRITISH JOURNAL OF CANCER

    What is Dr. Koong's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Koong's National Provider Identifier (NPI) number is 1598803512.

    What common questions do patients ask about Dr. Koong?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Koong

    What is Dr. Albert Koong's specialty?

    Dr. Koong is a Radiation Oncologist near Houston, TX. A radiological oncologist specializes in the therapeutic applications of radiant energy and its modifiers. They focus on the study and management of diseases, particularly malignant tumors. Contact Dr. Koong to book an appointment today.

    Is this Dr. Albert Koong affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Koong is affiliated with The University of Texas MD Anderson Cancer Center which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    Where can I learn more about Radiation Oncologist?

    Explore Radiation Oncologist with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Albert Koong accepting new patients in Houston, TX?

    Yes, Dr. Albert Koong is accepting new patients at this time.

    Does Dr. Albert Koong offer online booking?

    Please contact Dr. Koong's office at (713) 792-6161 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Albert Koong?

    Please contact Dr. Koong's office at (713) 792-6161 for information regarding telehealth appointment availability or for scheduling assistance.

    Which board certifications does Dr. Albert Koong have?

    Dr. Albert Koong is certified by the American Board of Radiology.

    Other Radiation Oncologist Near Houston, TX

    CW

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Houston, TX
    CT

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Houston, TX
    Dr. Steven Lin, MD, PHD

    Radiation Oncologist

    acceptingPatients-iconAccepting patients
    Houston, TX
    See All Specialists

    Doctors by Category

    Specialists